Dean Wagner

Dean Wagner possesses extensive experience in medical affairs and business development, currently serving as Executive Director at Inhibrx Biosciences, Inc. since October 2022, following a progression from Senior Director roles in both Medical Affairs and Medical Strategy. Prior to this, Dean held various leadership positions at Travere Therapeutics from August 2016 to September 2022, and was involved in business intelligence and market research at Janssen, Pharmaceutical Companies of Johnson and Johnson, as a Post-Doc Fellow. Early career experience includes internships in pharmacy and regulatory affairs. Academic qualifications include a Bachelor of Science in Molecular Genetics and a Doctor of Pharmacy from The Ohio State University.